Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mereo Biopharma Group Plc

1.79
+0.08505.00%
Volume:1.55M
Turnover:2.77M
Market Cap:283.99M
PE:-5.64
High:1.82
Open:1.74
Low:1.74
Close:1.70
52wk High:5.02
52wk Low:1.47
Shares:159.10M
Float Shares:100.47M
Volume Ratio:2.03
T/O Rate:1.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3162
EPS(LYR):-0.2924
ROE:-74.61%
ROA:-35.13%
PB:5.24
PE(LYR):-6.10

Loading ...

Aug 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Jul 10, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2025

Major Issues Report

Form 8-K - Current report
Jan 23, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities